13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 37 holding rows worth $1,920,378,000.
- Accession
- 0001654954-17-001060
- Filer
- CIK 1444043
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 37 entries on the cover page, a total value of $1,920,378,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,920,378,000 with VALUE read as thousands by filing date, 13F file number 028-13745. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 4,724,450 | $171,261,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 4,145,889 | $158,166,000 | thousands by filing date | |
| Stryker Corporation | 863667101 | COM | 1,000,000 | $119,810,000 | thousands by filing date | put |
| ALLERGAN PLC | G0177J108 | SHS | 543,000 | $114,035,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 1,500,000 | $107,415,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 1,208,200 | $100,558,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 6,025,000 | $79,831,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 6,000,000 | $73,620,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 2,458,100 | $72,244,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 1,000,000 | $71,610,000 | thousands by filing date | call |
| BROOKDALE SR LIVING INC | 112463104 | COM | 5,500,000 | $68,310,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 4,060,000 | $67,680,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 3,902,000 | $64,266,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 2,500,000 | $60,525,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 1,000,000 | $55,580,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 750,000 | $55,253,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,500,000 | $54,270,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 1,200,000 | $53,964,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 175,000 | $49,626,000 | thousands by filing date | |
| UNIVERSAL AMERN CORP NEW | 91338E101 | COM | 4,875,000 | $48,506,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 300,000 | $43,863,000 | thousands by filing date | |
| Abbott Laboratories | 028241000 | COM | 1,000,000 | $38,410,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 750,000 | $33,128,000 | thousands by filing date | |
| ATHENAHEALTH INC | 04685W103 | COMMON STOCK | 300,000 | $31,551,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 611,390 | $21,276,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 3,635,000 | $20,792,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 2,347,593 | $19,720,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 2,398,123 | $19,041,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 200,000 | $11,302,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 10,180,000 | $10,587,000 | thousands by filing date | |
| BIOLASE INC | 909911108 | WARRANTS | 5,332,394 | $7,465,000 | thousands by filing date | |
| ARENA PHARMECEUTICALS INC | 040047102 | COMMON STOCK | 4,250,000 | $6,035,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 9,000,000 | $4,579,000 | thousands by filing date | principal |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 1,000,000 | $3,610,000 | thousands by filing date | |
| TARGACEPT INC | 87611RAA6 | NOTE 2/1 | 1,684,799 | $1,685,000 | thousands by filing date | principal |
| DEXTERA SURGICAL INC COM | 252366109 | CS | 837,483 | $804,000 | thousands by filing date | |
| BIOLASE INC | 909911108 | WARRANTS | 1,841,173 | $0 | thousands by filing date | callValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-17-001060 | this filing | 2017-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001654954-17-002061 | base | 2017-03-16 | acceptance time not in the bulk data set |